ATOSSA THERAPEUTICS, INC. Other Current Liabilities
ATOSSA THERAPEUTICS, INC. (ATOS) had Other Current Liabilities of $1.12 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Current $1.12M.
- 2026-03-31: Other Liabilities, Current $1.14M.
- 2025-12-31: Other Liabilities, Current $1.10M.
- 2025-09-30: Other Liabilities, Current $1.57M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.12M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.14M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.10M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.57M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.56M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.53M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.51M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.48M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.79M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.83M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.80M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $21.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $46.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $65.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $19.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $27.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $31.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $13.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $21.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $18.25K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $21.28K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $7.70K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $4.00K 10-K · filed 2022-02-28 | $4.75K 10-K · filed 2021-03-31 |
| 2020-09-30 | $14.67K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $6.19K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.46K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $12.89K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $18.41K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $19.84K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $9.86K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $39.94K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $66.08K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $23.33K 10-Q/A · filed 2018-11-13 | |
| 2018-03-31 | $23.32K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $15.53K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $13.29K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $19.16K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $22.40K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $6.08K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $18.89K 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $22.73K 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $3.85K 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | $64.13K 10-K/A · filed 2017-03-21 | |
| 2015-09-30 | $22.60K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $20.27K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $42.91K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $42.23K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $12.38K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $4.62K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $10.19K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $8.15K 10-K · filed 2015-03-30 | $23.65K 10-K · filed 2014-03-27 |
| 2013-09-30 | $20.30K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $31.65K 10-Q · filed 2013-08-14 | |
| 2012-12-31 | $32.03K 10-K · filed 2014-03-27 | $0.00 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |